Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial
- DOI
- 10.1016/s2352-3018(25)00356-x
- Published
- 2026-07
- Container
- The Lancet HIV
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s2352-3018-25-00356-x,
title = {Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial},
author = {Sharana Mahomed and Carmen A Paez and Yunda Huang and Kelly E Seaton and Chenchen Yu and Kevin Gillespie and Maurine D Miner and Shelly T Karuna and Theresa Gamble and Jack Heptinstall and Elize Domin and Haili Tang and Lu Zhang and Fei Gao and Margaret Yacovone and Hans M L Spiegel and Julie Dumond and Maija A Anderson and Estelle Piwowar-Manning and Bonnie J Dye and India Tindale and Lori Proulx-Burns and Meg Trahey and Simbarashe Takuva and Azwidihwi Takalani and Veronique C Bailey and Spyros A Kalams and Hyman Scott and Josphat Kosgei and Sinéad Delany-Moretlwe and Sheetal Kassim and Fatima Laher and Z Mike Chirenje and Yeukai Musodza and Felix Mhlanga and Nonhlanhla Mkhize and Joshua A Weiner and Margaret E Ackerman and M Juliana McElrath and Michael N Pensiero and Lucio Gama and Dan H Barouch and Lawrence Corey and Myron S Cohen and David C Montefiori and Georgia D Tomaras and Marc Siegel and Colleen F Kelley and Margaret E. Ackerman and Maija A Anderson and Michael Archibald and Kathryn Axelrod and Veronique C. Bailey and Saman Baral and Dan H. Barouch and Gail Broder and Wairimu Chege and Shawn Chiambah and Kelvin Chiong and Z. Mike Chirenje and Myron S. Cohen and Lawrence Corey and Sinéad Delany-Moretlwe and Elize Domin and Jaiden Dumas and Julie Dumond and Bonnie J. Dye and Lucio Gama and Theresa Gamble and Fei Gao and Kevin Gillespie and Chelsea Greer and Jen Hanke and Nicholas Hastings and Jack Heptinstall and Nate Holm and Yunda Huang and Zoe Jones and Spyros A. Kalams and Geoffrey Kamau and Shelly T. Karuna and Sheetal Kassim and Colleen Kelley and Robert Klitzman and Josphat Kosgei and Gabriela Kovacikova and Fatima Laher and Judith Lucas and Jonathan Lucas and Sharana Mahomed and Anders McConachie and M. Juliana McElrath and Tara McNair and Felix Mhlanga and Maurine D. Miner and Nonhlanhla Mkhize and David C. Montefiori and Amber Moser and Yeukai Musodza and Carmen A. Paez and Michael N. Pensiero and Estelle Piwowar-Manning and Lori Proulx-Burns and Lynette Purdue and April Randhawa and Laurie Rinn and Sheetal Sawant and Hyman Scott and Kelly E. Seaton and Angelina Sharak and Marc Siegel and Hans M.L. Spiegel and Kenneth R. Stroop and Shonda E. Sumner and Azwidihwi Takalani and Simbarashe Takuva and Haili Tang and India Tindale and Georgia D. Tomaras and Meg Trahey and Lenka Tswenyana and Melissa Turner and Joshua A. Weiner and Haven Wilvich and Margaret Yacovone and Nicole Yates and Hannah Yellin and Ntando Yola and Chenchen Yu and Lu Zhang},
year = {2026},
journal = {The Lancet HIV},
doi = {10.1016/s2352-3018(25)00356-x},
url = {https://doi.org/10.1016/s2352-3018(25)00356-x}
}RIS
TY - JOUR TI - Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial AU - Sharana Mahomed AU - Carmen A Paez AU - Yunda Huang AU - Kelly E Seaton AU - Chenchen Yu AU - Kevin Gillespie AU - Maurine D Miner AU - Shelly T Karuna AU - Theresa Gamble AU - Jack Heptinstall AU - Elize Domin AU - Haili Tang AU - Lu Zhang AU - Fei Gao AU - Margaret Yacovone AU - Hans M L Spiegel AU - Julie Dumond AU - Maija A Anderson AU - Estelle Piwowar-Manning AU - Bonnie J Dye AU - India Tindale AU - Lori Proulx-Burns AU - Meg Trahey AU - Simbarashe Takuva AU - Azwidihwi Takalani AU - Veronique C Bailey AU - Spyros A Kalams AU - Hyman Scott AU - Josphat Kosgei AU - Sinéad Delany-Moretlwe AU - Sheetal Kassim AU - Fatima Laher AU - Z Mike Chirenje AU - Yeukai Musodza AU - Felix Mhlanga AU - Nonhlanhla Mkhize AU - Joshua A Weiner AU - Margaret E Ackerman AU - M Juliana McElrath AU - Michael N Pensiero AU - Lucio Gama AU - Dan H Barouch AU - Lawrence Corey AU - Myron S Cohen AU - David C Montefiori AU - Georgia D Tomaras AU - Marc Siegel AU - Colleen F Kelley AU - Margaret E. Ackerman AU - Maija A Anderson AU - Michael Archibald AU - Kathryn Axelrod AU - Veronique C. Bailey AU - Saman Baral AU - Dan H. Barouch AU - Gail Broder AU - Wairimu Chege AU - Shawn Chiambah AU - Kelvin Chiong AU - Z. Mike Chirenje AU - Myron S. Cohen AU - Lawrence Corey AU - Sinéad Delany-Moretlwe AU - Elize Domin AU - Jaiden Dumas AU - Julie Dumond AU - Bonnie J. Dye AU - Lucio Gama AU - Theresa Gamble AU - Fei Gao AU - Kevin Gillespie AU - Chelsea Greer AU - Jen Hanke AU - Nicholas Hastings AU - Jack Heptinstall AU - Nate Holm AU - Yunda Huang AU - Zoe Jones AU - Spyros A. Kalams AU - Geoffrey Kamau AU - Shelly T. Karuna AU - Sheetal Kassim AU - Colleen Kelley AU - Robert Klitzman AU - Josphat Kosgei AU - Gabriela Kovacikova AU - Fatima Laher AU - Judith Lucas AU - Jonathan Lucas AU - Sharana Mahomed AU - Anders McConachie AU - M. Juliana McElrath AU - Tara McNair AU - Felix Mhlanga AU - Maurine D. Miner AU - Nonhlanhla Mkhize AU - David C. Montefiori AU - Amber Moser AU - Yeukai Musodza AU - Carmen A. Paez AU - Michael N. Pensiero AU - Estelle Piwowar-Manning AU - Lori Proulx-Burns AU - Lynette Purdue AU - April Randhawa AU - Laurie Rinn AU - Sheetal Sawant AU - Hyman Scott AU - Kelly E. Seaton AU - Angelina Sharak AU - Marc Siegel AU - Hans M.L. Spiegel AU - Kenneth R. Stroop AU - Shonda E. Sumner AU - Azwidihwi Takalani AU - Simbarashe Takuva AU - Haili Tang AU - India Tindale AU - Georgia D. Tomaras AU - Meg Trahey AU - Lenka Tswenyana AU - Melissa Turner AU - Joshua A. Weiner AU - Haven Wilvich AU - Margaret Yacovone AU - Nicole Yates AU - Hannah Yellin AU - Ntando Yola AU - Chenchen Yu AU - Lu Zhang PY - 2026 JO - The Lancet HIV DO - 10.1016/s2352-3018(25)00356-x UR - https://doi.org/10.1016/s2352-3018(25)00356-x ER -
APA
Mahomed, S., Paez, C. A., Huang, Y., Seaton, K. E., Yu, C., Gillespie, K., Miner, M. D., Karuna, S. T., Gamble, T., Heptinstall, J., Domin, E., Tang, H., Zhang, L., Gao, F., Yacovone, M., Spiegel, H. M. L., Dumond, J., Anderson, M. A., Piwowar-Manning, E., Dye, B. J., Tindale, I., Proulx-Burns, L., Trahey, M., Takuva, S., Takalani, A., Bailey, V. C., Kalams, S. A., Scott, H., Kosgei, J., Delany-Moretlwe, S., Kassim, S., Laher, F., Chirenje, Z. M., Musodza, Y., Mhlanga, F., Mkhize, N., Weiner, J. A., Ackerman, M. E., McElrath, M. J., Pensiero, M. N., Gama, L., Barouch, D. H., Corey, L., Cohen, M. S., Montefiori, D. C., Tomaras, G. D., Siegel, M., Kelley, C. F., Ackerman, M. E., Anderson, M. A., Archibald, M., Axelrod, K., Bailey, V. C., Baral, S., Barouch, D. H., Broder, G., Chege, W., Chiambah, S., Chiong, K., Chirenje, Z. M., Cohen, M. S., Corey, L., Delany-Moretlwe, S., Domin, E., Dumas, J., Dumond, J., Dye, B. J., Gama, L., Gamble, T., Gao, F., Gillespie, K., Greer, C., Hanke, J., Hastings, N., Heptinstall, J., Holm, N., Huang, Y., Jones, Z., Kalams, S. A., Kamau, G., Karuna, S. T., Kassim, S., Kelley, C., Klitzman, R., Kosgei, J., Kovacikova, G., Laher, F., Lucas, J., Lucas, J., Mahomed, S., McConachie, A., McElrath, M. J., McNair, T., Mhlanga, F., Miner, M. D., Mkhize, N., Montefiori, D. C., Moser, A., Musodza, Y., Paez, C. A., Pensiero, M. N., Piwowar-Manning, E., Proulx-Burns, L., Purdue, L., Randhawa, A., Rinn, L., Sawant, S., Scott, H., Seaton, K. E., Sharak, A., Siegel, M., Spiegel, H. M., Stroop, K. R., Sumner, S. E., Takalani, A., Takuva, S., Tang, H., Tindale, I., Tomaras, G. D., Trahey, M., Tswenyana, L., Turner, M., Weiner, J. A., Wilvich, H., Yacovone, M., Yates, N., Yellin, H., Yola, N., Yu, C., & Zhang, L. (2026). Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial. The Lancet HIV. https://doi.org/10.1016/s2352-3018(25)00356-x
Source records
- crossref · retrieved 2026-09-26T10:39:58.540Z